Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2014 1
2015 1
2016 2
2019 1
2020 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
RNA disruption indicates CHOP therapy efficacy in canine lymphoma.
Parissenti AM, Pritzker LB, Guo B, Narendrula R, Wang SX, Lin LL, Pei J, Skowronski K, Bienzle D, Woods JP, Pritzker KPH, Coomber BL. Parissenti AM, et al. Among authors: pritzker lb. BMC Vet Res. 2019 Dec 16;15(1):453. doi: 10.1186/s12917-019-2189-x. BMC Vet Res. 2019. PMID: 31842875 Free PMC article.
Tumor RNA disruption predicts survival benefit from breast cancer chemotherapy.
Parissenti AM, Guo B, Pritzker LB, Pritzker KP, Wang X, Zhu M, Shepherd LE, Trudeau ME. Parissenti AM, et al. Among authors: pritzker lb. Breast Cancer Res Treat. 2015 Aug;153(1):135-44. doi: 10.1007/s10549-015-3498-9. Epub 2015 Jul 25. Breast Cancer Res Treat. 2015. PMID: 26208483
Bioinformatics advances for clinical biomarker development.
Pritzker KP, Pritzker LB. Pritzker KP, et al. Among authors: pritzker lb. Expert Opin Med Diagn. 2012 Jan;6(1):39-48. doi: 10.1517/17530059.2012.634797. Epub 2011 Nov 4. Expert Opin Med Diagn. 2012. PMID: 23480619
RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Toomey S, Eustace AJ, Pritzker LB, Pritzker KP, Fay J, O'Grady A, Cummins R, Grogan L, Kennedy J, O'Connor D, Young L, Kay EW, O'Donovan N, Gallagher WM, Kalachand R, Crown J, Hennessy BT. Toomey S, et al. Among authors: pritzker lb. J Natl Cancer Inst. 2016 Jul 4;108(8):djw111. doi: 10.1093/jnci/djw111. Print 2016 Aug. J Natl Cancer Inst. 2016. PMID: 27377904 Free PMC article. No abstract available.